SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurobiological Tech (NTII)
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
1494 40 0 NTII
Emcee:  Miles Rhyne Hoffman, CFA Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1269george - great post ... JohnJohn McCarthy-1/7/2004
1268<i> I am not arguing with you </i> Always welcome all view points amopgcw-1/7/2004
1267I am not arguing with you ... just want to point out that several of the news reJohn McCarthy-1/7/2004
1266Seeking help about ANY drug that suppresses something called the BACE1 enzyme. John McCarthy-1/7/2004
1265GS Take (Note concern at end): Forest Laboratories EPS (FY Mar) 2004E $1.86, mopgcw-1/7/2004
1264NTII is one of four companies that will be presenting at J.M. Dutton's HealtJMarcus-1/7/2004
1263Nig - this is gonna help too (I think) Reuters Pfizer says UK patients are denJohn McCarthy-1/7/2004
1262Lundbeck Reports Positive Study Results on Ebixa Drug Wednesday January 7, 9:02 nigel bates-1/7/2004
1261UPDATE - Forest to submit new application for Namenda drug Wednesday January 7, John McCarthy-1/7/2004
1260Namenda(TM) (Memantine HCl) Mild to Moderate Alzheimer's Disease Studies RepJohn McCarthy-1/7/2004
1259Neurobiological Tech Raised to `Speculative Buy' at Taglich 2003-12-03 10:48mopgcw-12/3/2003
1258follow-up about vaccines ..... Mindset first to receive patent for Alzheimer`s John McCarthy-11/30/2003
1257Into the Darkness of the Mind Alzheimer’s cost U.S. businesses about $61 billiJohn McCarthy-11/30/2003
1256SPC Granted to Merz for memantine. The recent grant of a UK Supplementary ProteJohn McCarthy-11/26/2003
1255Wow, thanks for the very perceptive legal advice, Marc. (Is your wife taking netom pope-11/19/2003
1254I've gone over to the dark side in more ways than one. First, I posted on tJMarcus-11/19/2003
1253Thanks for the kind words, John. But my efforts are pitifully small compared toJMarcus-11/17/2003
1252Marc - there are no words that would accurately convey my appreciation of your sJohn McCarthy-11/15/2003
1251Here are a few more notes on the stockholders meeting. Two of the issues up forJMarcus-11/15/2003
1250Found it. From the following page of NTII's website, you can link to the 10JMarcus-11/13/2003
1249<<<<<<<<<<<<< I am told that a redacted cJohn McCarthy-11/13/2003
1248Marc - thank you for all your efforts in summarizing the details of the cc andJohn McCarthy-11/13/2003
1247Just returned from the stockholders meeting. Not much new, but I'll post soJMarcus-11/13/2003
1246(part 2 of 2) Pfizer filed an NDA for a “son of neurontin” drug for DN. It is PJMarcus-11/13/2003
1245I'll be heading off to the stockholders meeting in a few minutes now. Last JMarcus-11/13/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News